Cited by 627Migraine and Headache StudiesMusculoskeletal pain and rehabilitationTraumatic Brain Injury Research

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

Blumenfeld, AM, Varon, SF, Wilcox, TK, Buse, DC, Kawata, AK, Manack, A, Goadsby, PJ, Lipton, RB·2011·Cephalalgia

Open this paper in CoChat — free account

Abstract

Background: Migraine imposes significant burden on patients, their families and health care systems. In this study, we compared episodic to chronic migraine sufferers to determine if migraine status predicted headache-related disability, health-related quality of life (HRQoL) and health care resource utilization. Methods: A Web-based survey was administered to panelists from nine countries. Participants were classified as having chronic migraine (CM), episodic migraine (EM) or neither using a validated questionnaire. Data collected and then analyzed included sociodemographics, clinical characteristics, Migraine Disability Assessment, Migraine-Specific Quality of Life v2.1, Patient Health Questionnaire and health care resource utilization. Findings: Of the respondents, 5.7% had CM and 94.3% had EM, with CM patients reporting significantly more severe disability, lower HRQoL, higher levels of anxiety and depression and greater health care resource utilization compared to those with EM. Interpretation: These results provide evidence that will enhance our understanding of the factors driving health care costs and will contribute to development of cost-effective health care strategies.

Integrity signals

Registry

Crossref · 10.1177/0333102410381145

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261
The global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Self-citation
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Self-citation
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Self-citation
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Self-citation
The Global Burden of Disease Study
Menken, M., Munsat, T. L., & Toole, J. F. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.418 · Cited by 1,059

Show all 50 references

Research works printed but not linked: 4

Harwood RH, 2004, Bull World Health Organ, 82, 251
Hung PH, 2006, Acta Neurol Taiwan, 15, 43
Kroenke K, 2009, Psychosomatics, 50, 613
Stewart WF, 1994, Neurology, 44, S24

Sorted by citations

Items 201–300 of 626

Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial
Lipton, R. B., Pozo‐Rosich, P., Blumenfeld, A. M., Li, Y., Severt, L., Stokes, J., Creutz, L., Gandhi, P., & Dodick, D. W. (2022) · Neurology · doi:10.1212/wnl.0000000000201568 · Cited by 35
Self-citation
Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study
Buse, D. C., Powers, S. W., Gelfand, A. A., VanderPluym, J. H., Fanning, K. M., Reed, M. L., Adams, A. M., & Lipton, R. B. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13254 · Cited by 30
Self-citation
Living with migraine: A meta-synthesis of qualitative studies
Battista, S., Lazzaretti, A., Coppola, I., Maistrello, L. F., Rania, N., & Testa, M. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1129926 · Cited by 31
The Effect of Orem's Self-Care Model on Quality of Life in Patients with Migraine: a Randomized Clinical Trial.
Zarandi, F. M., Raiesifar, A., & Ebadi, A. (2016) · PubMed · Cited by 31
Migraña crónica: definición, epidemiología, factores de riesgo y tratamiento
Carod-Artal, F. J., Sieira, P. I., & Echevarri, D. E. (2012) · Revista de Neurología · doi:10.33588/rn.5410.2012170 · Cited by 31
Cost-Effectiveness of Long-Term, Targeted OnabotulinumtoxinA versus Peripheral Trigger Site Deactivation Surgery for the Treatment of Refractory Migraine Headaches
Schoenbrunner, A. R., Khansa, I., & Janis, J. E. (2019) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000006480 · Cited by 31
Rapid referral for headache management from emergency department to headache centre: four years data
Negro, A., Spuntarelli, V., Sciattella, P., & Martelletti, P. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01094-6 · Cited by 31
Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples
Teixeira, A. L., Costa, E. A. C., da Silva, A. A., dos Santos, I. A. M., Gómez, R. S., Kümmer, A., & Lauterbach, E. C. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0480-3 · Cited by 31
Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data
Davies, B., Gaul, C., Martelletti, P., García‐Moncó, J. C., & Brown, S. M. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0802-6 · Cited by 30
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK
Hollier-Hann, G., Curry, A. S., Onishchenko, K., Akehurst, R. L., Ahmed, F., Davies, B., & Keyzor, I. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1675417 · Cited by 30
Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden
Mahon, R., Lang, A., Vo, P. G., Huels, J., Cooney, P., Danyliv, A., Vudumula, U., Vadapalle, S., Maniyar, F., & Goadsby, P. J. (2021) · PharmacoEconomics · doi:10.1007/s40273-020-00996-2 · Cited by 30
Self-citation
Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis
Johnston, K., Popoff, E., Deighton, A. M., Dabirvaziri, P., Harris, L. A., Thiry, A., Croop, R. S., Coric, V., L’Italien, G., & Moren, J. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1945444 · Cited by 30
Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey
García‐Azorín, D., Moya-Alarcón, C., Armada, B., & del Río, M. S. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01740-3 · Cited by 29
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures
Goadsby, P. J., Barbanti, P., Lambru, G., Ettrup, A., Christoffersen, C. L., Josiassen, M. K., Phul, R., & Sperling, B. (2022) · European Journal of Neurology · doi:10.1111/ene.15670 · Cited by 29
Self-citation
The Impact of Post‐Traumatic Stress Disorder on the Burden of Migraine: Results From the National Comorbidity Survey‐Replication
Rao, A. S., Scher, I., Vieira, R. V. D. A., Merikangas, K. R., Metti, A. L., & Peterlin, B. L. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12698 · Cited by 29
The Efficacy of Physical Therapy and Rehabilitation Approaches in Chronic Migraine: A Systematic Review and Meta-Analysis
Onan, D., Ekizoğlu, E., Arıkan, H., Taşdelen, B., Özge, A., & Martelletti, P. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2205126 · Cited by 28
Early efficacy and late gain in chronic and high‐frequency episodic migraine with onabotulinumtoxinA
Alpuente, A., Gallardo, V. J., Torres‐Ferrús, M., Álvarez‐Sabín, J., & Pozo‐Rosich, P. (2019) · European Journal of Neurology · doi:10.1111/ene.14028 · Cited by 28
Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome
Speck, R. M., Shalhoub, H., Ayer, D. W., Ford, J. H., Wyrwich, K. W., & Bush, E. N. (2019) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-019-0138-x · Cited by 28
Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine
Lipton, R. B., Lee, L., Saikali, N. P., Bell, J., & Cohen, J. M. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.20103 · Cited by 28
Self-citation
A long-term open-label safety study of galcanezumab in Japanese patients with migraine
Hirata, K., Takeshima, T., Sakai, F., Tatsuoka, Y., Suzuki, N., Igarashi, H., Nakamura, T., Ozeki, A., Yamazaki, H., & Skljarevski, V. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1866536 · Cited by 28
The Utility of a Novel, Combined Biofeedback-Virtual Reality Device as Add-on Treatment for Chronic Migraine
Cuneo, A. Z., Yang, R., Zhou, H., Wang, K., Goh, S., Wang, Y., Raiti, J., Krashin, D. L., & Murinova, N. (2023) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000001114 · Cited by 27
Is There a Relationship between Throbbing Pain and Arterial Pulsations?
Mirza, A. F., Mo, J., Holt, J. L., Kairalla, J. A., Heft, M. W., Ding, M., & Ahn, A. H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0193-12.2012 · Cited by 28
Age- and sex-related differences in the presentation of paediatric migraine: A retrospective cohort study
Wilcox, S. L., Ludwick, A., Lebel, A., & Borsook, D. (2017) · Cephalalgia · doi:10.1177/0333102417722570 · Cited by 28
Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial
Yu, S., Guo, A., Wang, Z., Liu, J., Tan, G., Yang, Q., Zhang, M., Yibulaiyin, H., Chen, D., Zhang, Y., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01731-4 · Cited by 27
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
Blumenfeld, A. M., Aurora, S. K., Laranjo, K., & Papapetropoulos, S. (2015) · BMC Neurology · doi:10.1186/s12883-015-0353-x · Cited by 28
Self-citation
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study
Tepper, S. J., Fang, J., Vo, P. G., Shen, Y. H., Zhou, L., Abdrabboh, A., Glassberg, M. B., & Ferraris, M. L. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01238-2 · Cited by 27
Relationships between headache frequency, disability, and disability-related unemployment among adults with migraine
Shapiro, R. E., Martin, A., Bhardwaj, S., Thomson, H., Maculaitis, M. C., Anderson, C., & Kymes, S. M. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.2.197 · Cited by 27
Chronic daily headaches
Ahmed, F., Parthasarathy, R., & Khalil, M. (2012) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.100002 · Cited by 27
Diagnosis and treatment for chronic migraine
Moriarty, M., & Mallick‐Searle, T. (2016) · The Nurse Practitioner · doi:10.1097/01.npr.0000483078.55590.b3 · Cited by 27
Health Behaviors in Episodic Migraine: Why Behavior Change Matters
Rosenberg, L., Butler, N., & Seng, E. K. (2018) · Current Pain and Headache Reports · doi:10.1007/s11916-018-0721-5 · Cited by 27
Measures of Functioning in Patients With Episodic Migraine: Findings From a Double‐Blind, Randomized, Placebo‐Controlled Phase 2b Trial With Galcanezumab
Ayer, D. W., Skljarevski, V., Ford, J. H., Nyhuis, A. W., Lipton, R. B., & Aurora, S. K. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13383 · Cited by 27
Self-citation
Brainstem 1H-MR spectroscopy in episodic and chronic migraine
Lai, T., Fuh, J., Lirng, J.-F., Lin, C., & Wang, S. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0491-0 · Cited by 27
Importance of Pain Acceptance in Relation to Headache Disability and Pain Interference in Women With Migraine and Overweight/Obesity
Lillis, J., Thomas, J. G., Seng, E. K., Lipton, R. B., Pavlovic, J. M., Rathier, L. A., Roth, J. L., O’Leary, K. C., & Bond, D. S. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13058 · Cited by 26
Self-citation
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine
Ford, J. H., Foster, S. A., Stauffer, V. L., Ruff, D. D., Aurora, S. K., & Versijpt, J. J. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s182563 · Cited by 26
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis
Dudeney, J., Sharpe, L., McDonald, S., Menzies, R. E., & McGuire, B. (2022) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14260 · Cited by 26
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care
Adams, A. M., Buse, D. C., Leroux, É., Lantéri‐Minet, M., Sakai, F., Matharu, M. S., Katsarava, Z., Reed, M. L., Fanning, K. M., Sommer, K., et al. (2023) · Cephalalgia · doi:10.1177/03331024231180611 · Cited by 28
Self-citation
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
Blumenfeld, A. M., Lipton, R. B., Silberstein, S. D., Tepper, S. J., Charleston, L. I., Landy, S. H., Kuruvilla, D. E., & Adams, A. M. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00529-x · Cited by 26
Self-citation
OnabotulinumtoxinA for chronic migraine: a critical appraisal
Ahmed, F., & Gooriah, R. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s76964 · Cited by 26
Migraine, weight gain and the risk of becoming overweight and obese: A prospective cohort study
Winter, A. C., Wang, L., Buring, J. E., Sesso, H. D., & Kurth, T. (2012) · Cephalalgia · doi:10.1177/0333102412455708 · Cited by 26
Onabotulinumtoxin‐A in Chronic Migraine: Should Timing and Definition of Non‐Responder Status Be Revised? Suggestions From a Real‐Life Italian Multicenter Experience
Vernieri, F., Paolucci, M., Altamura, C., Pasqualetti, P., Mastrangelo, V., Pierangeli, G., Cevoli, S., D’Amico, D., & Grazzi, L. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13617 · Cited by 26
My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland
Sumelahti, M., Sumanen, M. P. T., Sumanen, M. S., Tuominen, S., Vikkula, J., Honkala, S. M., Rosqvist, S., & Korolainen, M. A. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01185-4 · Cited by 26
Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)
Ailani, J., Andrews, J. S., Rettiganti, M. R., & Nicholson, R. A. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01190-7 · Cited by 26
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study
Lantéri‐Minet, M., Goadsby, P. J., Reuter, U., Wen, S., Hours-Zesiger, P., Ferrari, M. D., & Klatt, J. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324396 · Cited by 27
Self-citation
Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment
Buse, D. C., Pozo‐Rosich, P., Benjamin, L., Balkaran, B. L., Lee, L., Jauregui, A., Gandhi, P., Parikh, M., & Reuter, U. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01655-5 · Cited by 25
Self-citation
Concordant Occipital and Supraorbital Neurostimulation Therapy for Hemiplegic Migraine; Initial Experience; A Case Series
Reed, K. L., Will, K., Conidi, F., & Bulger, R. (2015) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12267 · Cited by 25
Differences in central facilitation between episodic and chronic migraineurs in nociceptive-specific trigeminal pathways
Sohn, J., Kim, C.-H., & Choi, H. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0637-6 · Cited by 25
Wearing Off Effect of OnabotulinumtoxinA Near the End of Treatment Cycle for Chronic Migraine: A 4‐Year Clinical Experience
Khan, F., Mohammed, A., Poongkunran, M., Chimakurthy, A., & Pepper, M. S. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13713 · Cited by 25
Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
Johnston, K., L'Italien, G. J., Popoff, E., Powell, L. C., Croop, R. S., Thiry, A., Harris, L. A., Coric, V., & Lipton, R. B. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01897-2 · Cited by 24
Self-citation
Association between dietary caffeine intake and severe headache or migraine in US adults
Zhang, L., Yin, J., Li, J., Sun, H., Liu, Y., & Yang, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-36325-8 · Cited by 24
Association Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA
Friedman, L. E., Zhong, Q., Gelaye, B., Williams, M. A., & Peterlin, B. L. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13235 · Cited by 24
When Mom Has Migraine: An Observational Study of the Impact of Parental Migraine on Adolescent Children
Seng, E. K., Mauser, E. D., Marzouk, M. A., Patel, Z. S., Rosen, N. L., & Buse, D. C. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13433 · Cited by 24
Self-citation
Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
Hirata, K., Ueda, K., Ye, W., Kim, Y., Komori, M., Jackson, J., Cotton, S. E., Rajan, N., & Treuer, T. (2020) · BMC Neurology · doi:10.1186/s12883-020-01848-4 · Cited by 23
Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)
Ford, J. H., Tassorelli, C., Leroux, É., Wang, S., Ayer, D. W., Nichols, R., & Detke, H. C. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02623-1 · Cited by 23
Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
Blumenfeld, A. M., Patel, A. T., Turner, I. M., Mullin, K., Adams, A. M., & Rothrock, J. F. (2020) · Journal of Primary Care & Community Health · doi:10.1177/2150132720959936 · Cited by 23
Self-citation
Disability, burden, and symptoms related to sensitization in migraine patients associate with headache frequency
Antonio, S. D., Castaldo, M., Ponzano, M., Bovis, F., Torelli, P., Finocchi, C., & Arendt‐Nielsen, L. (2021) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0050 · Cited by 23
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine
Argyriou, A. A., Mantovani, E., Mitsikostas, D. D., Vikelis, M., & Tamburin, S. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2091435 · Cited by 23
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study
Landy, S. H., Munjal, S., Brand‐Schieber, E., & Rapoport, A. M. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0881-z · Cited by 23
A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe
Ford, J. H., Foster, S. A., Nichols, R., Tockhorn‐Heidenreich, A., Ye, W., Jackson, J., & Cotton, S. E. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00221-w · Cited by 22
Real-world Experience with Remote Electrical Neuromodulation in the Acute Treatment of Migraine
Tepper, S. J., Lin, T., Montal, T., Ironi, A., & Dougherty, C. O. (2020) · Pain Medicine · doi:10.1093/pm/pnaa299 · Cited by 22
Association of migraines with brain tumors: a nationwide population-based study
Chen, C.-H., Sheu, J., Lin, Y.-C., & Lin, H. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0944-1 · Cited by 21
Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study
Kollewe, K., Gaul, C., Gendolla, A., & Sommer, K. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01260-4 · Cited by 23
Depression in headaches
Deligianni, C. I., Vikelis, M., & Mitsikostas, D. D. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328352c416 · Cited by 21
Professional tools and a personal touch–experiences of physical therapy of persons with migraine
Rutberg, S., Kostenius, C., & Öhrling, K. (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2012.748838 · Cited by 25
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME ( US ) study
Ashina, S., Muenzel, E. J., Nicholson, R. A., Zagar, A. J., Buse, D. C., Reed, M. L., Shapiro, R. E., Hutchinson, S. L., Pearlman, E. M., & Lipton, R. B. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14729 · Cited by 21
Self-citation
A Critical Evaluation on MOH Current Treatments
Negro, A., Curto, M., Lionetto, L., Guérzoni, S., Pini, L. A., & Martelletti, P. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0465-2 · Cited by 21
Assessing Physician‐Patient Dialogues About Chronic Migraine During Routine Office Visits
Buse, D., Gillard, P., Arctander, K., Kuang, A. W., & Lipton, R. (2018) · Headache · doi:10.1111/head.13314 · Cited by 19
Self-citation
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
Hirata, K., Sakai, F., Takeshima, T., Imai, N., Matsumori, Y., Yoshida, R., Numachi, Y., Peng, C., Mikol, D. D., & Cheng, S. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01313-8 · Cited by 20
Ambient NO2 exposure induces migraine in rats: Evidence, mechanisms and interventions
Ye, S., Li, S., Ma, Y., Wei, L. J., Zeng, Y., Hu, D., & Xiao, F. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.157102 · Cited by 21
Personality in Chronic Headache: A Systematic Review with Meta-Analysis
Bottiroli, S., Renzi, A., Ballante, E., Icco, R. D., Sances, G., Tanzilli, A., Vecchi, T., Tassorelli, C., & Galli, F. (2023) · Pain Research and Management · doi:10.1155/2023/6685372 · Cited by 23
Considerations for management of migraine symptoms in the primary care setting
Silberstein, S. D. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1175912 · Cited by 20
Prognosis Following Discontinuation of OnabotulinumA Therapy in “Super‐responding” Chronic Migraine Patients
Ching, J., Tinsley, A., & Rothrock, J. F. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13630 · Cited by 20
The effect of greater occipital nerve blockade on the quality of life, disability and comorbid depression, anxiety, and sleep disturbance in patients with chronic migraine
Ulusoy, E. K., & Bolattürk, Ö. F. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04286-9 · Cited by 23
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
Stauffer, V. L., Turner, I. M., Kemmer, P., Kielbasa, W., Day, K. A., Port, M. D., Quinlan, T., & Camporeale, A. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01148-9 · Cited by 20
Economic burden of medication-overuse headache in Iran: direct and indirect costs
Togha, M., Nadjafi-Semnani, F., Martami, F., Mohammadshirazi, Z., Vahidpour, N., Akbarisari, A., & Daroudi, R. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04716-8 · Cited by 20
The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis
Schmidt, K., Berding, T., Kleine‐Borgmann, J., Engler, H., Holle, D., Gaul, C., & Bingel, U. (2021) · Pain · doi:10.1097/j.pain.0000000000002341 · Cited by 21
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group
Sacco, S., Russo, A., Geppetti, P., Grazzi, L., Negro, A., Tassorelli, C., Tedeschi, G., & Martelletti, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1825077 · Cited by 19
Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions
Raciti, L., Raciti, G., Militi, D., Casella, C., & Calabrò, R. S. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2105141 · Cited by 24
Variations in Patterns of Utilization and Charges for the Care of Low Back Pain in North Carolina, 2000 to 2009: A Statewide Claims’ Data Analysis
Hurwitz, E. L., Li, D., Guillen, J., Schneider, M., Stevans, J. M., Phillips, R. B., Phelan, S. P., Lewis, E. A., Armstrong, R. C., & Vassilaki, M. E. (2016) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2016.02.006 · Cited by 19
Role of greater occipital nerve block for preventive treatment of chronic migraine: A critical review
Chowdhury, D., & Mundra, A. (2020) · Cephalalgia Reports · doi:10.1177/2515816320964401 · Cited by 19
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study
Shibata, M., Nakamura, T., Ozeki, A., Ueda, K., & Nichols, R. (2020) · Journal of Pain Research · doi:10.2147/jpr.s287781 · Cited by 19
Behavioral Weight Loss Treatments for Individuals with Migraine and Obesity
Cervoni, C., Bond, D. S., & Seng, E. K. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-016-0540-5 · Cited by 19
Development of the Cogniphobia Scale for Headache Disorders (CS-HD): A pilot study.
Seng, E. K., & Klepper, J. E. (2017) · Psychological Assessment · doi:10.1037/pas0000432 · Cited by 19
Healthcare resource use and costs associated with the misdiagnosis of migraine
Kim, J. R., Park, T., Agapova, M., Blumenfeld, A. M., Smith, J. H., Shah, D., & Devine, B. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14822 · Cited by 18
Self-citation
Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab
Blumenfeld, A. M., Ettrup, A., Hirman, J., Ebert, B., & Cady, R. K. (2022) · BMC Neurology · doi:10.1186/s12883-022-02774-3 · Cited by 18
Self-citation
Aryl hydrocarbon receptors improve migraine‐like pain behaviors in rats through the regulation of regulatory T cell/T‐helper 17 cell‐related homeostasis
Yang, L., Zhou, Y., Zhang, L., Wang, Y., Zhang, Y., & Xiao, Z. (2023) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14599 · Cited by 18
Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis
Medrea, I., Cooper, P. E., Lagman-Bartolome, A. M., Sandoe, C. H., Amoozegar, F., Hussain, M. W., Bradi, A. C., Dawe, J., Guay, M., Perreault, F., et al. (2024) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2024.285 · Cited by 19
A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine
Starling, A. J., & Vargas, B. B. (2015) · Current Pain and Headache Reports · doi:10.1007/s11916-015-0521-0 · Cited by 18
Travelling along a road with obstacles: Experiences of managing life to feel well while living with migraine
Rutberg, S., Öhrling, K., & Kostenius, C. (2013) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.3402/qhw.v8i0.19900 · Cited by 18
Diferencias entre migraña crónica con y sin uso excesivo de medicación: experiencia en una serie hospitalaria de 434 pacientes
Rojo, E., Pedraza, M. I., Muñoz, I., Mulero, P., Ruíz, M., de la Cruz, C., Barón, J., Rodríguez, C., Herrero, S., & Peral, Á. L. G. (2014) · Neurología · doi:10.1016/j.nrl.2013.12.003 · Cited by 18
Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine
Sacco, S., Benemei, S., Cevoli, S., Coppola, G., Cortelli, P., Cesaris, F. D., Icco, R. D., Marco, C. M. D., Lorenzo, C. D., Geppetti, P., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0966-3 · Cited by 17
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials
Lipton, R. B., Singh, R. B. H., Revicki, D. A., Zhao, S., Shewale, A. R., Lateiner, J. E., & Dodick, D. W. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01419-7 · Cited by 17
Self-citation
Eptinezumab improved patient‐reported outcomes in patients with migraine and medication‐overuse headache: Subgroup analysis of the randomized PROMISE ‐2 trial
Starling, A. J., Cowan, R. P., Buse, D. C., Diener, H., Marmura, M. J., Hirman, J., Brevig, T., & Cady, R. K. (2023) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14434 · Cited by 19
Self-citation
Psychological and Behavioral Factors Involved in Temporomandibular Myalgia and Migraine: Common but Differentiated Profiles
Viñals, A. C., Sánchez, T. S., García-González, M., García, I. A., Cid-Verdejo, R., Romero, E. A. S., & Jiménez‐Ortega, L. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021545 · Cited by 19
Phenotype of new daily persistent headache: subtypes and comparison to transformed chronic daily headache
Cheema, S., Stubberud, A., Rantell, K. R., Nachev, P., Tronvik, E., & Matharu, M. S. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01639-5 · Cited by 17
Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients
Pavlovic, J. M., Yu, J. S., Silberstein, S. D., Reed, M. L., Kawahara, S. H., Cowan, R. P., Dabbous, F., Campbell, K. L., Shewale, A. R., Pulicharam, R., et al. (2019) · Cephalalgia · doi:10.1177/0333102418825373 · Cited by 17
Self-citation
Eptinezumab for migraine prevention in patients 50 years or older
Martin, V. T., Tassorelli, C., Ettrup, A., Hirman, J., & Cady, R. K. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13603 · Cited by 16
Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
Khalil, M., Moreno‐Ajona, D., Villar‐Martínez, M. D., Greenwood, F., Hoffmann, J., & Goadsby, P. J. (2022) · European Journal of Neurology · doi:10.1111/ene.15364 · Cited by 16
Self-citation
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial
Lipton, R. B., Singh, R. B. H., Mechtler, L. L., McVige, J. W., Ma, J., Yu, S. Y., Stokes, J., Dabruzzo, B., Gandhi, P., & Ashina, M. (2023) · Cephalalgia · doi:10.1177/03331024231190296 · Cited by 16
Self-citation
Effects of probiotic and vitamin D co-supplementation on clinical symptoms, mental health, and inflammation in adult patients with migraine headache: a randomized, triple-blinded, placebo-controlled trial
Tirani, S. A., Khorvash, F., Saneei, P., Moradmand, Z., & Askari, G. (2024) · BMC Medicine · doi:10.1186/s12916-024-03684-6 · Cited by 19
Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society
Paemeleire, K., Louis, P., Magis, D., Vandenheede, M., Versijpt, J. J., Vandersmissen, B., & Schoenen, J. E. (2014) · Acta Neurologica Belgica · doi:10.1007/s13760-014-0313-z · Cited by 16

Authors: Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R.
Affiliations: The Neurology Center, USA.
Allergan (United States) (US)
United BioSource Corporation, USA.
Albert Einstein College of Medicine (US)
University of California, USA.
Montefiore Headache Center and Albert Einstein College of Medicine, USA.
Corresponding author: Blumenfeld, AM
Venue: Cephalalgia
Publisher: SAGE Publications
Published: 2010-09-02
Volume: 31
Issue: 3
Pages: 301-315
ISSN: 0333-1024 (ISSN-L)
1468-2982
DOI: 10.1177/0333102410381145
OpenAlex: W2142670324
Cited by: 627
References: 50
Citations by year: 2026: 22 · 2025: 34 · 2024: 53 · 2023: 50 · 2022: 41 · 2021: 58 · 2020: 79 · 2019: 49 · 2018: 39 · 2017: 25 · 2016: 34 · 2015: 38 · 2014: 26 · 2013: 27 · 2012: 38
FWCI: 16.79
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Cephalalgia (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Keywords: chronic migraine, episodic migraine, headache-related disability, health-related quality of life, healthcare resource utilization, anxiety, depression, health care costs
MeSH terms: Adult, Chronic Disease, Cross-Sectional Studies, Data Collection, Disability Evaluation, Female, Health Resources, Humans, Male, Migraine Disorders, Online Systems, Quality of Life, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks